Clinical Trial

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

Study acronym: ReplaceCysto
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether there are any differences in urinary symptoms, discomfort, number of invasive procedures, anxiety, complications, cancer recurrence or cancer progression when some cystoscopy procedures are replaced with urine testing.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2023-03-21; most recent amendment 2026-05-01.
Status change: Not Yet Recruiting → Recruiting 2023-11-16
Trial Details
NCT Number NCT05796375
Lead Sponsor White River Junction Veterans Affairs Medical Center
Collaborators: National Cancer Institute (NCI), University of Texas Southwestern Medical Center, Medical University of South Carolina
Conditions Non-muscle-invasive Bladder Cancer
Enrollment 240 participants
Start Date 2023-11-17
Primary Completion 2028-11-30 (estimated)
Study Completion 2028-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05